Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.
Health Technology Assessment (HTA) is rapidly becoming the most powerful driver of drug price setting and market access in LATAM... Learn More
Join us live on May 15, 2014... Learn More
View Webinar schedule and archive
See which reports have been searched on the most.
Come join us for an exciting one-day seminar.
Walk away with expert insights on ACOs,
Exchanges and the impact of Healthcare Reform.
View the Agenda | Meet our expert speakers
April 17, 2014
The Path Less Travelled Could be the Launch Pad for Novel Antibiotics in China
Surveyed U.S. Physicians Expect Strong Uptake of Novel Oral Anticoagulants for the Treatment of VTE
April 15, 2014
Surveyed European Neurologists Expect to Prescribe Biogen Idec’s Tecfidera to 16 Percent of their Diagnosed Relapsing-Remitting Multiple Sclerosis Patients in the Next 12 Months
NSCLC (EGFR-Mutation-Positive; Previously Treated)
Treatment decisions for non-small-cell lung cancer (NSCLC) patients are increasingly based on personalized... Read More
Acute Moderate to Severe Postoperative Pain: How Will U.S. Prescribers and Payers Determine the Success of Emerging Pain Therapies in the Hospital Setting?
Although the postoperative pain market is sizeable in terms of both dollars and the potential patient pool, treatment... Read More
Alzheimer’s Disease (Mild to Moderate)
With aging populations, the seven major pharmaceutical markets face an ever-expanding Alzheimer’s disease (AD) patient... Read More